Lung factor

The Lung factor research group’s operations are based on close co-operation with skilled basic investigators. Our most important partners include:

Docent Katri Koli, Growth factor group, Translational Cancer Biology Research Program, University of Helsinki.

Finnish Institute of Occupational Health (FIOH): chief medical officer Henrik Wolff, PhD Eeva Kettunen, professor Tapio Vehmas and  Kirsti Husgafvel-Pursiainen.

Docent Mikko Rönty, Pathology department, Fimlab Laboratories.

Professor Tiina Saarto, Palliative Center, Comprehensive Cancer Center, HUS.

Chief medical officer Juho Lehto, Palliative Care Unit, TAYS.

Professor Magnus Sköld, Karolinska Institutet.

In addition, professor Marjukka Myllärniemi coordinates the Finnish IPF register management team, The Finnish IPF Consortium. The IPF Consortium has a representative of each university hospital: Finnish Fibrosis Consortium: professor Riitta Kaarteenaho, Oulu University Central Hospital; docent Eija-Riitta Salomaa, M.D. Anne Böök and M.D. Jaana Kaunisto, Turku University Central Hospital; docent Seppo Saarelainen and professor Hannu Kankaanranta, Tampere University Central Hospital; M.D. Ph.D. Minna Purokivi, Kuopio University Hospital; M.D. Ph.D. Ulla Hodgson, Helsinki University Hospital.

Now at Lung factor / News

Ethical board approval for the FikSu -study

The ethical board at the Helsinki University Central Hospital has […]

BMC Pulm Med classifies our work as highly accessed

Our systematic review on IPF epidemiology has been ranked as […]

Finnish update on IPF in Duodecim

In the latest issue of Duodecim,  Finnish researchers publish an […]

Follow us on Facebook

Are you interested in our research? Please like us on […]

Archive »